Respiratory tract infections (RTIs) encompass a broad range of infections affecting the respiratory system, including the upper and lower respiratory tracts. These infections are commonly caused by viruses, bacteria, or other pathogens and can manifest as colds, flu, bronchitis, pneumonia, or more severe respiratory illnesses. RTIs typically spread through respiratory droplets produced when an infected person coughs or sneezes. Common symptoms include cough, congestion, sore throat, runny nose, and difficulty breathing. Viral RTIs, such as influenza and the common cold, are often self-limiting and can be managed with supportive care. Bacterial RTIs, like pneumonia, may require antibiotic treatment. Preventive measures for RTIs include vaccination, good hygiene practices like handwashing, avoiding close contact with sick individuals, and promoting overall respiratory health. RTIs pose a significant global health burden, contributing to morbidity and mortality, particularly in vulnerable populations. Ongoing research focuses on understanding the pathogens involved, developing effective treatments, and improving preventive strategies to reduce the impact of respiratory tract infections worldwide.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States